ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2026
Differential cannabinergic effects on temporal perception and production.
Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Evidence for pro-cognitive benefits of cannabinoids in people with bipolar disorder.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026Trial
- Abstract Representation of Movement Parameters in Basal Ganglia Output.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cannabinoids have traditionally been associated with motor and cognitive impairments, including slowness of movement and altered temporal perception. However, it remains unclear whether cannabinoids specifically affect the perception and/or production of temporal intervals. To explore these possibilities, we evaluated the effects of systemic administrations of the synthetic cannabinoid CP55940 on behavioral performance in male rats trained in three distinct paradigms designed to assess time interval perception and production. Systemic administration of CP55940 caused temporal overestimation in a fixed-interval task, which was primarily linked to impaired perception of elapsed time in the range of tens of seconds. In contrast, while the same treatment increased forelimb reach duration in a two-interval production task (in the hundreds of milliseconds range), these effects were more accurately attributed to a general reduction in movement speed rather than altered temporal processing. These findings were further confirmed in a third motor task, where animals executed a complex timed motor sequence with spatiotemporal constraints while running on a treadmill. Here, CP55940 administration slowed locomotion but did not disrupt motor timing. Our results demonstrate that, in addition to inducing motor slowness, systemic cannabinoid administration impairs temporal perception but preserves interval production, suggesting distinct underlying mechanisms for these two processes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.